Bone Marrow Osteoblast Damage by Chemotherapeutic Agents

• Stephanie L. Rellick ,

  Contributed equally to this work with: Stephanie L. Rellick, Heather O'Leary

  Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• Heather O'Leary ,

  Contributed equally to this work with: Stephanie L. Rellick, Heather O'Leary

  Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• Debbie Piktel,

  Affiliation Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• Cheryl Walton,

  Affiliation Department of Pediatrics, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• James E. Fortney,

  Affiliation Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• Stephen M. Akers,

  Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• Karen H. Martin,

  Affiliation Department of Neurobiology and Anatomy, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• James Denvir,

  Affiliation Department of Statistics, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• Goran Boskovic,

  Affiliation Microarray Core Facility, Marshall University, Huntington, West Virginia, United States of America

  ⨯
• Donald A. Primerano,

  Affiliation Microarray Core Facility, Marshall University, Huntington, West Virginia, United States of America

  ⨯
• Jeffrey Vos,

  Affiliation West Virginia University Department of Pathology, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America,

  ⨯
• Nathanael Bailey,

  Affiliation West Virginia University Department of Pathology, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America,

  ⨯
• Marieta Gencheva,

  Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯
• Laura F. Gibson

  * E-mail: lgibson@hsc.wvu.edu

  Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America

  ⨯